Pharmaphorum media bias and reliability
Ad Fontes Media places Pharmaphorum in the centre. We have seen it on 7 published stories of ours.
The short answers
Is Pharmaphorum biased?
Ad Fontes Media places Pharmaphorum in the centre. An outlet rating describes a broad pattern in its output, not every article it publishes.
Is Pharmaphorum left or right?
Ad Fontes Media places Pharmaphorum in the centre. In the three-way grouping used on story pages, that puts it under Centre.
Is Pharmaphorum reliable?
The factual-reliability assessments we hold for Pharmaphorum are Ad Fontes Media: High factuality. These are outlet-level assessments, not a guarantee that every report is correct.
What Pharmaphorum has been covering
Our account of each story, written from every outlet that ran it, with Pharmaphorum’s own report linked underneath.
House Democrats aim to swiftly address healthcare access and the Iran war upon taking majority control. Early legislative efforts will focus on boosting Medicaid and restoring Affordable Care Act subsidies, alongside efforts to end the Iran war and reverse trade tariffs.
Pharmaphorum reported it asWhat do midterms mean for Trump's pharma and health agenda? (opens Pharmaphorum in a new tab)
An artificial intelligence model can predict cancer patients' survival risk and biological aging from a single facial photograph. The research, conducted by Mass General Brigham, used a model trained on over 40 million facial images.
Pharmaphorum reported it asAI tool uses face photos to predict cancer survival (opens Pharmaphorum in a new tab)
Pharmaceutical giant AstraZeneca is teaming up with technology firm Oracle to leverage artificial intelligence and real-world data. The partnership seeks to enhance clinical research by improving patient recruitment for trials and monitoring safety signals, with initial efforts focused on several key disease areas.
Pharmaphorum reported it asAZ and Oracle team up on AI platform for clinical trials (opens Pharmaphorum in a new tab)
Bayer will invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, creating approximately 600 high-value jobs and 1,500 construction jobs. The facility is expected to be operational in phases starting in 2031.
Pharmaphorum reported it asBayer pledges $2.2bn to US manufacturing facility (opens Pharmaphorum in a new tab)
Novo Nordisk and Anthropic have announced a collaboration to use artificial intelligence in drug discovery and development. Novo Nordisk will employ Anthropic's Claude models, including Claude Science, to advance its research and development efforts.
Pharmaphorum reported it asNovo taps Anthropic's Claude AI for drug discovery (opens Pharmaphorum in a new tab)
A genetically modified pig kidney functioned in a human patient for a record 271 days, allowing the individual to avoid dialysis while awaiting a human transplant. The results were published in The Lancet by doctors from Massachusetts General Hospital and Harvard Medical School.
Pharmaphorum reported it asPig to human kidney transplantation hits a new milestone (opens Pharmaphorum in a new tab)
The Trump administration announced new drug pricing agreements with nine pharmaceutical companies. These deals are intended to align U.S. prices with those paid in other developed countries, impacting state Medicaid programs.
Pharmaphorum reported it asWhite House signs pricing deals with nine more pharmas (opens Pharmaphorum in a new tab)
Who says so
One organisation has published a rating for this outlet. Where they disagree, the disagreement is the useful part and it is left standing.
- Ad Fontes MediacenterCheck it
How reliably it reports fact
A rating of the newsroom in general, by others, and a different thing from the Trust score we publish on each story, which judges one piece of reporting.
High factuality
- Ad Fontes MediahighCheck it
Who owns it
We hold no ownership record for Pharmaphorum.
Where it publishes from
- Official site
- pharmaphorum.com
- Seen publishing on
- pharmaphorum.com
- Access
- Free to read
What we have seen ourselves
Counted across the stories this site has published, which is the only denominator a reader can check: every one of them has a page, and every page lists the reports it was written from.
- Stories
- 7
- Reports listed
- 7
- We could read
- 0
- First seen
- 7 August 2026
7 of those reports were paywalled or blocked to us. Our reading of this outlet is built on the 0 we could open, not on everything it published.
A blindspot is measured against one side of the spectrum. Pharmaphorum is rated centre, so there is no side for it to be counted against and we publish no figure here.
Across the 7 stories of ours where at least three of the reports we listed carried a time, another outlet was always ahead of Pharmaphorum: its report arrived a median of 21 hours after the earliest one we logged.
Measured 8 November 2026. Last seen in a coverage list 7 November 2026. Ratings pulled 10 October 2026.
Other outlets rated the same way
Publishers carrying the same published leaning as Pharmaphorum, ordered by how often we have seen them on a story. Sharing a rating is not the same as being alike.
Think this page is wrong?
The leanings above are published by AllSides, Ad Fontes Media and Media Bias/Fact Check, and we republish them rather than make them. If you think one is misapplied, the strongest place to say so is with the organisation that made it, and every verdict here links to their page.
What we are responsible for is everything else: the ownership chain, where Pharmaphorum publishes from, which of our stories we have listed it on, and whether we have the right publisher at all. Tell us what is wrong and an editor reads it.
Report something wrong on this page
Anything we correct is written up in the public corrections log. We do not publish reader votes as a rating, because an unattributed rating is the thing this site exists to argue against.
Every rating on this page is a named third party’s published work, republished with its author and, where one exists, a link to it. Our own coverage record is the section we measure ourselves. Neither is a judgement of any individual report: those are scored story by story, and the reasoning is on our methodology page.